Catelli Chiara, D'Alessandro Miriana, Mathieu Federico, Corzani Roberto, Ghisalberti Marco, Lloret Madrid Andrea, Guerrini Susanna, Paladini Piero, Luzzi Luca
Thoracic Surgery and Lung Transplant Unit, Department of Medicine, Surgery and Neurosciences, Azienda Ospedaliero-Universitaria Senese, University of Siena, 53100 Siena, Italy.
Respiratory Diseases Unit, Department of Medicine, Surgery and Neurosciences, Azienda Ospedaliero-Universitaria Senese, University of Siena, 53100 Siena, Italy.
J Pers Med. 2025 Aug 19;15(8):387. doi: 10.3390/jpm15080387.
To evaluate outcomes of patients undergoing lung segmentectomy using open thoracotomy, Video-Assisted Thoracoscopic Surgery (VATS), or Robotic-Assisted Thoracoscopic Surgery (RATS) approaches. A total of 157 patients (mean age: 68.7 years; 58% male) who underwent lung segmentectomy from 2015 to 2024 at the Thoracic Surgery of Siena were retrospectively enrolled and divided into groups based on the surgical approach: thoracotomy ( = 60), VATS ( = 58), and RATS ( = 39). No significant differences were observed between groups in terms of age, gender, or tumor stage. Peri-operative outcomes, and, in patients with non-small cell lung cancer (NSCLC, = 104), long-term outcomes, were analyzed. Group comparisons were conducted using Kruskal-Wallis, Dunn's test, Chi-squared, or Fisher's exact test and Kaplan-Meier analysis with log-rank test. Conversion rate was 13% and 0% for VATS and RATS, respectively ( = 0.005). Pleural effusion on first post-operative day was lower in RATS than VATS ( = 0.0006) and open ( < 0.0001). The maximum Visual Analogue Scale (VAS) value recorded was lower in RATS than open ( = 0.016) and VATS ( = 0.013). Surgery time was longer for RATS than open ( = 0.001) and VATS ( = 0.013). No differences were found in hospital stay and post-operative complications. In patients with NSCLC, the median follow-up was 25 months. The 90-day mortality rate was 9.5% in thoracotomy, 0% in VATS and RATS ( = 0.05). The 1- and 2-year overall survival was higher in VATS and RATS groups than thoracotomy ( = 0.001 and = 0.040, respectively). The number of harvested lymph nodes was larger in the open group ( = 0.010), while a higher number of stations were harvested in RATS and open than VATS ( = 0.001). No differences were found in local recurrence (= 0.08). RATS segmentectomy ensures a lower conversion rate, less post-operative pain, reduced daily pleural effusion, and a greater number of harvested lymph node stations compared to VATS, providing comparable peri-operative outcomes. RATS and VATS segmentectomy offer an advantage over the open approach in short- and long-term survival.
为评估采用开胸手术、电视辅助胸腔镜手术(VATS)或机器人辅助胸腔镜手术(RATS)进行肺段切除术患者的手术结果。回顾性纳入了2015年至2024年在锡耶纳胸外科接受肺段切除术的157例患者(平均年龄:68.7岁;58%为男性),并根据手术方式将其分为几组:开胸手术组(n = 60)、VATS组(n = 58)和RATS组(n = 39)。各组在年龄、性别或肿瘤分期方面未观察到显著差异。分析了围手术期结果,对于非小细胞肺癌(NSCLC,n = 104)患者,还分析了长期结果。采用Kruskal-Wallis检验、Dunn检验、卡方检验或Fisher精确检验以及带有对数秩检验的Kaplan-Meier分析进行组间比较。VATS组和RATS组的中转率分别为13%和0%(P = 0.005)。RATS组术后第一天的胸腔积液少于VATS组(P = 0.0006)和开胸手术组(P < 0.ooo1)。RATS组记录的最大视觉模拟量表(VAS)值低于开胸手术组(P = 0.016)和VATS组(P = 0.013)。RATS组的手术时间长于开胸手术组(P = 0.001)和VATS组(P = 0.013)。住院时间和术后并发症方面未发现差异。在NSCLC患者中,中位随访时间为25个月。开胸手术组的90天死亡率为9.5%,VATS组和RATS组为0%(P = 0.05)。VATS组和RATS组的1年和2年总生存率高于开胸手术组(分别为P = 0.001和P = 0.040)。开胸手术组切除的淋巴结数量更多(P = 0.010),而RATS组和开胸手术组切除的淋巴结站数多于VATS组(P = 0.001)。局部复发方面未发现差异(P = 0.08)。与VATS相比,RATS肺段切除术确保了更低的中转率、更少的术后疼痛、减少的每日胸腔积液以及更多的切除淋巴结站数,提供了可比的围手术期结果。RATS和VATS肺段切除术在短期和长期生存方面比开胸手术具有优势。